Beacon is the No. 1 oncology company of Bangladesh & manufactures latest anticancer drugs……..
It is being evaluated for use in numerous other cancers, including advanced prostate cancer.
Dasatinib is a cancer medicine that slows the growth and spread of cancer cells in the body.
Dasatinib – Wonder molecule for treating CML &(Ph+ ALL).
Dasanix is used to treat chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) when other cancer treatments have not been effective.
Dasatinib is an oral Bcr-Abl tyrosine kinase inhibitor (inhibits the “Philadelphia chromosome”) and Src family tyrosine kinase inhibitor approved for first line use in patients with chronic myelogenous leukemia (CML)and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It is being evaluated for use in numerous other cancers, including advanced prostate cancer.
Serving Breakthrough
Therapy
Know about chronic
myeloid Leukemia
Latest News
& Media
Beacon Introduces Global Patient Support Program
Life saving drugs are either beyond the reach of general people or not available in many countries. Because of the patient exemptions for Bangladeshi companies,Beacon Pharmaceuticals can manufacture the patented drugs. As a support to global patient…Read More
Registered & Licensed by Regulatory
Authority of Bangladesh
Dasanix is a registered product by the Directorate General of Drug Administration & Licensing Authority (Drugs) of Bangladesh. Drug Registration Number: 341-272-10 Inclusion Date: 06-09-2015 Valid up to: 05-09-2020